Evaluation of pulmonary TB treatment efficiency depending on polymorphism of glutathione-S-transferasexenobiotic biotransformation enzyme and on sensitivity profile Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016
Association of serum cytokines with pulmonary tuberculosis treatment outcomes Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014
Impact of diabetes on the presenting features of tuberculosis patients Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 Year: 2014
Progress of treatment delayed testicular tuberculosis: One case Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013
Acute phase reaction in pulmonary tuberculosis during treatment Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015
Side effects of chemical preparations in patients with drug-resistant pulmonary tuberculosis Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders Year: 2015
The change in serum Ca 19-9 levels according to treatment responses in pulmonary nontuberculous mycobacterial disease Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015
Rapid monitoring of tuberculosis treatment response: A multi-centre study Source: International Congress 2016 – Advances in tuberculosis diagnosis and monitoring of treatment Year: 2016
Link between clinical severity of osteoarticular tuberculosis and the combined presence of pulmonary tuberculosis Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016
Multiplexed cytokine and chemokine profiling in patients with latent tuberculosis infection: Treatment effect Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014
The effectiveness of pulmonary TB treatment in patients with organic liver diseases, depending on the way of administration of anti-TB drugs Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016
Tuberculosis in patients receiving treatment of TNF-alpha inhibitors Source: International Congress 2015 – Case series and clinical conundrums in TB Year: 2015
Influence of modern basic therapy of bronchial asthma (BA) on the course of pulmonary TB in patients with pulmonary TB associated with BA Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014
Restarting biologic agents in rheumatology patients who developed tuberculosis under TNFα-inhibitor treatment Source: International Congress 2015 – Latent TB infection and screening Year: 2015
Treatment effectiveness of TB patients from different groups of population in Moscow Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016
The influence of genotype allele HLA-DRB1* on the development of generalized forms of tuberculosis among children Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015
Combined collapse therapy in the treatment of cavitary pulmonary tuberculosis (CPTB) Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
Study of inflammatory markers in sputum positive patients of pulmonary tuberculosis and its response to anti-tubercular treatment Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Correlation between vitamin D receptor polymorphism with clinical and nutritional status in intensive phase treatment of pulmonary tuberculosis Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016
Effect of anti-tuberculosis treatment on body composition during the intensive phase Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016